WaferGen Bio systems Analysis
WaferGen Bio systems is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of WaferGen Bio delisted stock analysis is to determine its intrinsic value, which is an estimate of what WaferGen Bio systems is worth, separate from its market price. There are two main types of WaferGen Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect WaferGen Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of WaferGen Bio's stock to identify patterns and trends that may indicate its future price movements.
The WaferGen Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. WaferGen Bio is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. WaferGen Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and WaferGen Bio's ongoing operational relationships across important fundamental and technical indicators.
WaferGen |
WaferGen Stock Analysis Notes
About 20.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 5.93. WaferGen Bio systems had not issued any dividends in recent years. The entity had 1:5 split on the November 29, 2016. WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. For more information please call Rolland Carlson at 510-651-4450 or visit http://www.wafergen.com.WaferGen Bio systems Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. WaferGen Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding WaferGen Bio systems or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| WaferGen Bio systems is not yet fully synchronised with the market data | |
| WaferGen Bio systems has some characteristics of a very speculative penny stock | |
| WaferGen Bio systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 9.24 M. Net Loss for the year was (20.85 M) with profit before overhead, payroll, taxes, and interest of 3.95 M. | |
| WaferGen Bio systems currently holds about 5.15 M in cash with (13.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36. | |
| Roughly 20.0% of the company outstanding shares are owned by insiders |
WaferGen Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate WaferGen Bio's market, we take the total number of its shares issued and multiply it by WaferGen Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.WaferGen Profitablity
WaferGen Bio's profitability indicators refer to fundamental financial ratios that showcase WaferGen Bio's ability to generate income relative to its revenue or operating costs. If, let's say, WaferGen Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, WaferGen Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of WaferGen Bio's profitability requires more research than a typical breakdown of WaferGen Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (175.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (171.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $171.93.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding WaferGen Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |